Skip to content 
A pancreatic stent is needed when the pancreatic duct is blocked, narrowed, or leaking, and that obstruction is causing pain, recurrent pancreatitis, or interfering with drainage. The decision isn’t automatic. Some duct narrowings can be watched, others need urgent intervention, and the difference depends on symptoms, imaging, and whether the cause is something correctable on its own. Most stents go in during ERCP, sometimes with EUS guidance for difficult anatomy. The harder question for most patients isn’t whether stenting works, it’s whether they actually need one right now.
According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “Stenting is overused in some centres and underused in others. A patient with mild chronic pancreatitis and minor duct changes doesn’t always need a stent. A patient with a tight stricture and recurrent pain definitely does. Getting that judgment right is what separates good pancreatic ERCP practice from procedural overuse.”
Which are the Conditions that typically need stenting?
The indications fall into a handful of clear categories, and most cases that get stented fall into one of these patterns.
- Dominant strictures in chronic pancreatitis. A localised narrowing of the main duct, often with upstream dilatation visible on MRCP, in a patient with ongoing pain. Stenting the stricture relieves pressure and pain in around sixty to seventy percent of cases.
- Pancreatic duct stones, particularly when they’re impacted and causing recurrent pancreatitis. Removal comes first, sometimes with shockwave lithotripsy if the stones are large or hard, then the stent goes in to keep the duct open while the inflammation calms down.
- Pancreatic duct leak or disruption. Trauma, surgery, or severe pancreatitis can tear the duct. Pancreatic juice then leaks into surrounding tissue, sometimes forming pseudocysts or causing ascites. A transpapillary stent across the leak point usually allows it to heal.
- Some pancreatic cancers compressing the duct. Not all of them, only the small subset where ductal pressure is causing pain or recurrent pancreatitis and surgery isn’t an option, often in patients on chemotherapy who need symptom control.
Choosing which patients benefit isn’t always obvious from imaging alone. Pancreatic stone extraction work and stenting decisions usually happen together in the same procedure, with EUS sometimes added beforehand to assess the duct anatomy, exclude masses, and plan the approach properly.
When stenting is the wrong answer?
Not every blocked duct should be stented, and the reverse question matters as much as knowing when to do it.
- Asymptomatic minor duct changes. Mild narrowing on MRCP without pain, without recurrent pancreatitis, without functional impairment. Stenting these patients exposes them to procedure risk without clear benefit.
- Acute pancreatitis episodes themselves aren’t an indication for stenting in most cases. The duct usually clears on its own once inflammation settles. Premature stenting can make things worse rather than better.
- Diffuse strictures throughout the entire pancreatic duct. When the whole duct is narrowed rather than one focal segment, stenting one area doesn’t help much, and these patients often need surgical drainage rather than endoscopic stenting.
- Patients who can’t commit to the follow-up schedule. A stent left in for years causes more problems than it solved, and patients who can’t return for exchange every three to six months are often better managed with non-stenting strategies like enzyme replacement and pain management.
You don’t want a stent placed because something can be stented. You want one placed because the alternative was worse. Read more on pancreatic stenting for how the procedure itself works once that decision has been made.
Why choose Dr. Vipulroy Rathod for pancreatic stenting decisions?
Dr. Vipulroy Rathod has been managing pancreatic ERCP and stenting decisions at Fortis Hospital Mulund for over three decades, with particular focus on chronic pancreatitis where the question of who benefits from stenting is harder than it looks. Many patients arrive having been told they need urgent stenting based on imaging alone, when a closer look at their symptoms and pain pattern suggests they don’t. Others arrive having been managed non-procedurally for years when a single well-timed stent would have changed their pain trajectory significantly.
Knowing when not to stent is the harder skill. The procedure itself isn’t trivial, the complication rate isn’t zero, and the follow-up commitment is real. Patients who understand all of that before the first procedure tend to do better than those who weren’t told upfront.
Book your consultation today with one of India’s most experienced specialists for pancreatic disease assessment and stenting decisions.
Frequently Asked Questions
No. Many are managed perfectly well with enzyme replacement, pain medication, and lifestyle changes. Stenting is reserved for patients with dominant strictures, recurrent pancreatitis, or pain not controlled by conservative measures.
It depends. Pancreatic duct leak after trauma needs urgent stenting within days. A dominant stricture causing chronic pain can be planned electively. Acute pancreatitis usually doesn’t need urgent stenting at all.
For some patients yes, particularly those with milder duct changes and pain controlled by analgesia and enzyme replacement. For tight strictures causing recurrent pancreatitis, medication alone usually isn’t enough.
No. Plastic stents are exchanged every three to six months, and most patients eventually have them removed entirely once the underlying problem stabilises. Long-term stenting beyond a year or two is uncommon and usually means the underlying condition needs reassessment.
Reference links-
- ERCP and Pancreatic Stenting Guidelines, American Society for Gastrointestinal Endoscopy — https://www.asge.org/home/practice-support/guidelines
- Chronic Pancreatitis Management Standards, World Gastroenterology Organisation — https://www.worldgastroenterology.org/guidelines
